Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

β-Bisabolene

Copy Product Info
😃Good
Catalog No. T40578Cas No. 495-61-4

β-Bisabolene is a sesquiterpene natural product exhibiting cytotoxicity towards breast cancer cell lines, inducing apoptosis in MCF-10A, MDA-MB-231, and BT474 cells.

β-Bisabolene

β-Bisabolene

Copy Product Info
😃Good
Catalog No. T40578Cas No. 495-61-4
β-Bisabolene is a sesquiterpene natural product exhibiting cytotoxicity towards breast cancer cell lines, inducing apoptosis in MCF-10A, MDA-MB-231, and BT474 cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$31-In Stock
1 mL x 10 mM (in DMSO)$29-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
β-Bisabolene is a sesquiterpene natural product exhibiting cytotoxicity towards breast cancer cell lines, inducing apoptosis in MCF-10A, MDA-MB-231, and BT474 cells.
In vitro
β-Bisabolene exhibits selective cytotoxicity: for murine cells, the half-maximal inhibitory concentration (IC₅₀) is >200 μg/ml for normal cells Eph4, 65.49 μg/ml for breast cancer cells MG1361, and 48.99 μg/ml for breast cancer cells 4T1; for Homo sapiens breast cancer cells, the IC₅₀ is 114.3 μg/ml for normal mammary epithelial cells MCF-10A, 66.91 μg/ml for breast cancer cells MCF-7, 98.39 μg/ml for breast cancer cells MDA-MB-231, 70.62 μg/ml for breast cancer cells SKBR3, and 74.3 μg/ml for breast cancer cells BT474. [1]
In vivo
In vivo experiments demonstrated that β-Bisabolene effectively inhibited the growth of transplanted 4T1 mammary tumors, reducing tumor volume by 37.5% at the experimental endpoint. [1]
Chemical Properties
Molecular Weight204.35
FormulaC15H24
Cas No.495-61-4
SmilesC(CCC=C(C)C)(=C)[C@H]1CCC(C)=CC1
Relative Density.0.8673 g/cm3
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (391.49 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (16.15 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.8936 mL24.4678 mL48.9356 mL244.6782 mL
5 mM0.9787 mL4.8936 mL9.7871 mL48.9356 mL
10 mM0.4894 mL2.4468 mL4.8936 mL24.4678 mL
20 mM0.2447 mL1.2234 mL2.4468 mL12.2339 mL
50 mM0.0979 mL0.4894 mL0.9787 mL4.8936 mL
100 mM0.0489 mL0.2447 mL0.4894 mL2.4468 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy β-Bisabolene | purchase β-Bisabolene | β-Bisabolene cost | order β-Bisabolene | β-Bisabolene chemical structure | β-Bisabolene in vivo | β-Bisabolene in vitro | β-Bisabolene formula | β-Bisabolene molecular weight